These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31691356)

  • 1. Rationale, study design and methodology of the LANDMARC trial: a 3-year, pan-India, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitus.
    Das AK; Mithal A; Kumar KMP; Unnikrishnan AG; Kalra S; Thacker H; Sethi B; Ghosh R; Mathew A; Chodankar D; Mohanasundaram S; Menon SK; Trivedi C; Naqvi M; Kanade V; Salvi V; Chatterjee G; Rais N; Wangnoo SK; Chowdhury S; Zargar AH; Joshi S
    Diabet Med; 2020 May; 37(5):885-892. PubMed ID: 31691356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year trends from the LANDMARC trial: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcomes of type 2 diabetes mellitus.
    Das AK; Kalra S; Joshi S; Mithal A; Kumar K M P; Unnikrishnan AG; Thacker H; Sethi B; Chowdhury S; Ghosh R; Krishnan S; Nair A; Mohanasundaram S; Menon SK; Salvi V; Chodankar D; Thaker S; Trivedi C; Wangnoo SK; Zargar AH; Rais N
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00316. PubMed ID: 34856077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline characteristics of participants in the LANDMARC trial: A 3-year,
    Das AK; Mithal A; Joshi S; Kumar KMP; Kalra S; Unnikrishnan AG; Thacker H; Sethi B; Ghosh R; Kanade V; Nair A; Mohanasundaram S; Menon SK; Chodankar D; Salvi V; Trivedi C; Chatterjee G; Chowdhury S; Rais N; Wangnoo SK; Zargar AH
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00231. PubMed ID: 34277959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year trends from the LANDMARC study: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcome in patients with type 2 diabetes mellitus.
    Das AK; Kalra S; Joshi S; Mithal A; Kumar K M P; Unnikrishnan AG; Thacker H; Sethi B; Chowdhury S; Sugumaran A; Mohanasundaram S; Menon SK; Salvi V; Chodankar D; Thaker S; Trivedi C; Wangnoo SK; Zargar AH; Rais N
    Endocrinol Diabetes Metab; 2023 Mar; 6(2):e404. PubMed ID: 36722454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.
    Zhang X; Zhao S; Huang Y; Ma M; Li B; Li C; Zhu X; Xu X; Chen H; Zhang Y; Zhou C; Zheng Z
    J Am Heart Assoc; 2024 Jun; 13(11):e032626. PubMed ID: 38818935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the A1chieve study.
    Mohan V; Shah S; Saboo B
    J Assoc Physicians India; 2013 Jan; 61(1 Suppl):12-5. PubMed ID: 24482981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LongitudinAl Nationwide stuDy on Management And Real-world outComes of diabetes in India over 3 years (LANDMARC trial).
    Das AK; Kalra S; Joshi S; Mithal A; Kumar KMP; Unnikrishnan AG; Thacker H; Sethi B; Chowdhury S; Sugumaran A; Satpathy A; Gadekar A; Menon SK; Neogi R; Chodankar D; Trivedi C; Wangnoo SK; Zargar AH; Rais N;
    Endocrinol Diabetes Metab; 2023 Sep; 6(5):e422. PubMed ID: 37392036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses.
    Nanayakkara N; Curtis AJ; Heritier S; Gadowski AM; Pavkov ME; Kenealy T; Owens DR; Thomas RL; Song S; Wong J; Chan JC; Luk AO; Penno G; Ji L; Mohan V; Amutha A; Romero-Aroca P; Gasevic D; Magliano DJ; Teede HJ; Chalmers J; Zoungas S
    Diabetologia; 2021 Feb; 64(2):275-287. PubMed ID: 33313987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
    Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
    Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
    De Meulemeester J; Charleer S; Visser MM; De Block C; Mathieu C; Gillard P
    Diabetologia; 2024 Aug; 67(8):1527-1535. PubMed ID: 38787436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular Complications and Prevalence of Nocturia in Japanese Patients With Type 2 Diabetes Mellitus: The Dogo Study.
    Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Maruyama K; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Onji M; Tanigawa T; Matsuura B; Hiasa Y; Miyake Y
    Urology; 2016 Jul; 93():147-51. PubMed ID: 26995392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes.
    ; Ahmad I; ; Ali M; Hussain M;
    J Pak Med Assoc; 2024 Aug; 74(8):1441-1448. PubMed ID: 39160710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young-onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications.
    Middleton TL; Constantino MI; Molyneaux L; D'Souza M; Twigg SM; Wu T; Yue DK; Zoungas S; Wong J
    Diabet Med; 2020 Jun; 37(6):991-999. PubMed ID: 31968129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Profile of Elderly Patients (Over 90 Years) with Type 2 Diabetes Seen at a Diabetes Center in South India.
    Viswanathan M; Ranjit Mohan A; Ranjit U; Prasanna Kumar G; Philips R; Saravanan J; Ulagamathesan V; Ganesan US; Kumaradas GV; Rajendran AK; Thangarajan R; Rajendra P; Coimbatore Subramanian SR
    Diabetes Technol Ther; 2020 Feb; 22(2):79-84. PubMed ID: 31638436
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic syndrome in type 1 diabetes and its association with diabetes complications.
    Lee AS; Twigg SM; Flack JR
    Diabet Med; 2021 Feb; 38(2):e14376. PubMed ID: 32738821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic Microvascular Complications Among Children and Adolescents in Northwestern Tanzania: A Cross-Sectional Study.
    Msanga D; Reis K; Kayange N; Bakalemwa R; Kidenya B; Hau D; Mwanansao C; Mahamba D; Ottaru S; Kwiyolecha E; Peck R
    Ann Glob Health; 2020 Apr; 86(1):43. PubMed ID: 32346524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus.
    Klein R; Klein BE; Moss SE
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):90-6. PubMed ID: 8554220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Macro- and Microvascular Complications among Older Adults with Diagnosed Type 2 Diabetes: Findings from The Irish Longitudinal Study on Ageing.
    Tracey ML; McHugh SM; Fitzgerald AP; Buckley CM; Canavan RJ; Kearney PM
    J Diabetes Res; 2016; 2016():5975903. PubMed ID: 27294152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
    Olamoyegun M; Ibraheem W; Iwuala S; Audu M; Kolawole B
    Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.